Lockton is the world’s largest independent insurance brokerage providing customized solutions to meet your organization's risk, benefits and retirement needs.

Lockton delivers sixth consecutive year of double-digit growth.

Strong performance underscores quality client relationships, diversified business model, and a powerful long‑term investment strategy.Learn more

1 / 5

"Partnership" brand imagery
Our job is very simple – to make our clients’ business better.

Businesses are looking to brokers for more than just transactions. They want an adviser who can help them reach their business goals. Lockton has been changing the conversation with clients by seeking to understand their business and help them view those goals through a new lens.

Uncommonly Independent

We bring creative thinking and an entrepreneurial spirit to the insurance business and are uniquely positioned to help you succeed.

See our story

Latest news & insights

The worldwide shift to remote work has sparked new logistical and structural legal challenges that have warranted many countries to pass teleworking legislation. This article has been updated to include recent amendments to Ukraine’s home-based and remote working legislation from 2 May 2025.New Remote Working Legislation Around the World [Updated]

New Remote Working Legislation Around the World [Updated]

article
UPDATE: Oman has introduced new rules on remote work from 31 August 2025. More details below. With the rise of technology, work from home has been a steadily growing trend for many years. Remote working has exploded since Spring 2020 with quarantines, workplac ...
Read moreNew Remote Working Legislation Around the World [Updated]

Common crime insurance losses for private equity portfolio companies

Learn how private equity portfolio companies can mitigate employee theft, fraud, and crime-related financial losses.Learn how private equity portfolio companies can mitigate employee theft, fraud, and crime-related financial losses.

Cell & gene therapy: Preparing for the next phase of employer health plan risk

Cell and gene therapies remain rare for most employer health plans today, but expanding treatment access and new indications may increase exposure in the years ahead.Cell and gene therapies remain rare for most employer health plans today, but expanding treatment access and new indications may increase exposure in the years ahead.

Reminder: PCORI filing due July 31

The Patient-Centered Outcomes Research Institute filing and payment to the IRS is due by July 31, 2026, and applies to policy and plan years ending during the 2025 calendar year. The Patient-Centered Outcomes Research Institute filing and payment to the IRS is due by July 31, 2026, and applies to policy and plan years ending during the 2025 calendar year.
See all news and insights

With a global footprint of 150+ offices and partner offices, find one near you.

Find an office
global communication network concept

Ready to join the team?

We bring creative thinking and an entrepreneurial spirit to the insurance business. Search for available jobs in your area and apply today.
View jobs

We're here to help

We bring creative thinking and an entrepreneurial spirit to the insurance business and are uniquely positioned to help you succeed.

Ask an Expert